Forum Topic Pharmaceutical
  • Conversation: [Nuvisan Talk] - New small molecules capabilites & capacities

    • August 6, 2020 2:32 PM BST
    • Watch this registered talk to listen to our CEO, Dr Dietrich Bruchmann and COO, Dr Hans Lindner, exposing their view on NUVISAN integrated services from research to early clinical phase and how its full-fledged research unit in Berlin can better assist you.In this 45-minute presentation, we'll cover:- NUVISAN's wide range of services: from research to early clinical stage (Phase II).- Expansion of NUVISAN's portfolio with new small molecules drug discovery capabilities and capacities acquired from Bayer.- Live Q&A session.For more, please make an appointment with our sales team on or send an email to

      This post was edited by Valeriane Barjhoux at August 6, 2020 2:34 PM BST

Add Reputation

Do you want to add reputation for this member by this post?

or cancel